Stockreport

Avita Medical cuts 2023 commercial revenue guidance on longer hospital approval timelines [Seeking Alpha]

Avita Medical, Inc.  (RCEL) 
PDF RCEL stock had cut back the losses and was last unchanged at $12.54 after hours. Avita ( RCEL ) said it now sees full year commercial revenue of about $49.5M to $50.5 [Read more]